Controlled release formulations for oral administration
Номер патента: AP2003002763A0
Опубликовано: 31-03-2003
Автор(ы): Ashok Rampal, Gour Mukherji, Narayanan Badri N Vishwanathan, Rajeev Raghuvanshi
Принадлежит: Ranbaxy Lab Ltd
Опубликовано: 31-03-2003
Автор(ы): Ashok Rampal, Gour Mukherji, Narayanan Badri N Vishwanathan, Rajeev Raghuvanshi
Принадлежит: Ranbaxy Lab Ltd
Реферат: A pharmaceutical composition in the form of an oral controlled release solid dosage form comprising an effective amount of drug, or its pharmaceutically acceptable salts. It also relates to apharmaceutically composition that is suitable for once-a-day dosing regimen
Mosapride sustained-release formulation providing pharmacological and clinical effects with once-daily administration
Номер патента: US09962390B2. Автор: Byung Jin Kim,Yong Hee Kim,Min Soo Kim,Jong-Il Kim,Hee Yong Song,Youn Woong Choi,Myoung-Hwa Lim,Dae-Chul Ha. Владелец: Korea United Pharm Inc. Дата публикации: 2018-05-08.